美国GE医疗全球总裁安杜尼：“我对在华投资充满信心”

Core Viewpoint - GE Healthcare's CEO emphasizes China's role as a significant contributor to the global economy and the importance of its open cooperation for multinational companies [3][7]. Investment and Market Presence - GE Healthcare has established six production bases in China, employing approximately 7,000 people and expanding its local R&D team to 1,800, which has launched over 160 locally innovative products since 2011 [4]. - The company has committed to a five-year investment plan of 500 million yuan in its Tianjin base, with a new R&D center expected to open by the end of 2025 [5]. Innovation and Collaboration - The innovation centers in China are part of GE Healthcare's strategy to leverage local resources and expertise, particularly in software engineering, AI, and robotics [6]. - The company is focused on localizing its operations by designing and manufacturing products in China, which includes developing specific medical devices for the Chinese market [8]. Long-term Commitment - GE Healthcare's long-term commitment to the Chinese market is unwavering, as the company believes success in China is crucial for its global success [7]. - The CEO highlights the resilience of the Chinese market and the increasing demand for quality healthcare services, especially in western provinces [7].